Overview

Pharmacokinetics of XueBiJing in Patients With Sepsis

Status:
Completed
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
Pharmacokinetics and disposition of XueBiJing compounds in patients with sepsis
Phase:
N/A
Details
Lead Sponsor:
Southeast University, China
Collaborator:
Chinese Academy of Sciences